NativeMed review

NativeMed publishes monthly and three-month rates for NAD⁺ and sermorelin and names VialsRx as a possible dispensing partner. Its pharmacy page says assignment depends on the prescription, state and availability. The remaining practical gaps are the selected supply details, full three-month billing schedule, state eligibility and treatment-specific refund terms.

NativeMed (NativeMed, LLC of Miami, Florida) is a cash-pay telehealth storefront with a short, legible catalog: compounded semaglutide and tirzepatide for weight loss, and a longevity shelf of an NAD⁺ injection and sermorelin. That is the whole public menu, which is unusual in a category that tends toward sprawling menus. It states that there are no membership fees, the same price at any dose and free shipping, and it accepts HSA and FSA cards but not insurance. Its footer carries a LegitScript seal.

An online questionnaire is reviewed by an independent licensed clinician; live audio or video may be used when appropriate. NativeMed, LLC operates the platform and does not itself practice medicine or dispense. The current pharmacy-services page names VialsRx in Tomball, Texas as a possible partner, with the actual dispenser identified on the prescription label. State and product eligibility need confirmation. Terms allow possible separate Quest lab costs without stating a NAD⁺-specific requirement or price.

The refund policy generally makes subscription and one-time payments nonrefundable. Its limited cancellation exception is labeled for weight-loss care and includes an unspecified fee; it does not establish a refund right for NAD⁺ or sermorelin. Confirm those terms before ordering.

The NAD⁺ product selector shows $189/month when Monthly is selected and $160/month for the three-month plan. Sermorelin shows $159/month or $149/month for three months. The public selectors do not print the complete three-month first debit or establish whether payment is collected upfront or monthly. Ask for that schedule rather than assuming a calculated total is the actual charge.

Free shipping, same-price-at-every-dose treatment and no membership fee are advertised. The pages do not fully specify dose, concentration or injections per supply. Any required labs and separate fees also need confirmation. A weight-loss-specific cancellation exception should not be assumed to apply to these longevity products.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. NativeMed states that its NAD⁺ injections are compounded by state-licensed pharmacies and are not FDA-approved to diagnose, treat or prevent any condition, and its current pharmacy-services page names VialsRx as a possible dispensing partner. Compounded sterile products are still not reviewed by the FDA for purity and potency the way approved drugs are, and a named pharmacy is something you can check with that state's board of pharmacy. On the evidence, injected NAD⁺ has no controlled human outcome trials at all. The single human intravenous study was a pharmacokinetic pilot finding that infused NAD⁺ clears from plasma quickly, and the NAD⁺ forms with human trial data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, which reliably raise blood NAD⁺ levels. A raised biomarker is not a demonstrated clinical benefit, and none of the energy, cognition or anti-aging outcomes marketed around NAD⁺ injections rests on controlled human outcome data. Sermorelin acts on the growth-hormone axis through your own pituitary, a real mechanism with thin long-term human outcome data. Individual results vary.